Somatisation Disorder

Also known as: Somatization Disorder / Somatic Symptom Disorders / Somatic Symptom Disorder / Somatoform Disorders / Somatoform Disorder / Somatization disorder (disorder) / Polysomatizing disorder (disorder) / Briquets syndrome / Briquet's syndrome (disorder) / Briquet's syndrome / Undifferentiated somatoform disorder / Bodily distress disorder (disorder) / Somatoform disorder, unspecified / Somatoform disorder (disorder) / Psychogenic disorder NOS / Other specified nonpsychotic mental disorders / Other malaise / Neurasthenic neurosis / Neurasthenia / Nervous debility

Drug	Drug Name	Drug Description
DB01511	Delorazepam	A benzodiazepine used to manage severe anxiety disorders and insomnia.
DB12930	Opipramol	A medication to treat general anxiety and somatoform disorders.
DB01323	St. John's Wort	An herbal ingredient used in non-prescription therapeutic products for the short-term treatment of minor skin irritations, insomnia, depression, and anxiety.

Drug	Drug Name	Target	Type
DB01511	Delorazepam	GABA(A) Receptor	target
DB01511	Delorazepam	GABA(A) Receptor Benzodiazepine Binding Site	target
DB01323	St. John's Wort	P-glycoprotein 1	transporter
DB01323	St. John's Wort	Cytochrome P450 3A4	enzyme
DB01323	St. John's Wort	Cytochrome P450 2D6	enzyme
DB01323	St. John's Wort	Cytochrome P450 2C19	enzyme

Drug	Drug Name	Phase	Status	Count
DB00514	Dextromethorphan	2	Recruiting	1
DB00472	Fluoxetine	2	Recruiting	1
DB00458	Imipramine	2	Completed	1
DB01175	Escitalopram	3	Completed	1
DB00875	Flupentixol	Not Available	Unknown Status	1
DB01221	Ketamine	Not Available	Enrolling by Invitation	1
DB13384	Melitracen	Not Available	Unknown Status	1